Markets:

Overview

News

Currencies

International

Treasuries

Cardinal Health (NY:CAH)

191.30 +4.95 (+2.66%)

Streaming Delayed Price Updated: 1:35 PM EDT, May 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cardinal Health

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

18 19 Next >

NYSE:CAH stands out as a stock that provides good value for the fundamentals it showcases. ↗

April 30, 2024

CARDINAL HEALTH INC (NYSE:CAH) is an undervalued gem with solid fundamentals.

Via Chartmill

Peering Into Cardinal Health's Recent Short Interest ↗

April 29, 2024

Via Benzinga

A Repeat of 2022? 7 Defensive Stocks to Buy Before the Correction. ↗

April 24, 2024

These seven defensive stocks spanning various recession-resistant sectors can help protect your portfolio from a potential market downturn.

Via InvestorPlace

Don't overlook NYSE:CAH—a stock with solid growth prospects and a reasonable valuation. ↗

April 24, 2024

For those who appreciate growth without the sticker shock, CARDINAL HEALTH INC (NYSE:CAH) is worth considering.

Via Chartmill

$100 Invested In Cardinal Health 5 Years Ago Would Be Worth This Much Today ↗

April 23, 2024

Via Benzinga

Ford, Nvidia Among Top S&P 500 Stocks Monday; Tesla Extends Losses ↗

April 22, 2024

Ford, United Airlines and megacap AI stock Nvidia were big-cap winners.

Via Investor's Business Daily

Topics Artificial Intelligence Stocks

How Is The Market Feeling About Cardinal Health? ↗

April 08, 2024

Via Benzinga

NYSE:CAH: good value for what you're paying. ↗

April 05, 2024

CARDINAL HEALTH INC (NYSE:CAH) is probably undervalued for the fundamentals it is displaying.

Via Chartmill

NYSE:CAH, a growth stock which is not overvalued. ↗

April 02, 2024

For those who appreciate growth without the sticker shock, NYSE:CAH is worth considering.

Via Chartmill

The Top 3 Healthcare Stocks to Buy in April 2024 ↗

April 22, 2024

These are strong buy stocks within the healthcare industry that investors should watch in 2024 due to their strong returns.

Via InvestorPlace

Stocks Set To Snap Worst Losing Streak In Nearly 2 Years, Gold Sinks, Bitcoin Reclaims $66,000: What's Driving Markets Monday? ↗

April 22, 2024

U.S. stocks are poised to break a six-day losing streak, marking the end of the longest downward trend since September 2022.

Via Benzinga

Drug Distributing Giant Cardinal Health Will Not Renew OptumRx Distribution Pact, Stock Plunges ↗

April 22, 2024

Discover the latest updates on Cardinal Health's nonrenewal of OptumRx contracts. Explore its fiscal 2024 guidance and long-term targets amidst market shifts. Learn about its strategies to offset...

Via Benzinga

CPI Shock Waves: 3 Undervalued Stocks to Ride the Volatility ↗

April 15, 2024

Undervalued stocks can be great picks in a volatile stock market, especially when investors are locked into the next CPI report.

Via InvestorPlace

Here's How Much $1000 Invested In Cardinal Health 5 Years Ago Would Be Worth Today ↗

March 28, 2024

Via Benzinga

Here's How Much You Would Have Made Owning Cardinal Health Stock In The Last 5 Years ↗

March 15, 2024

Via Benzinga

Peering Into Cardinal Health's Recent Short Interest ↗

March 13, 2024

Via Benzinga

Wall Street Favorites: 3 Bargain Stocks With Strong Buy Ratings for April 2024 ↗

April 09, 2024

Buying value stocks can be a very profitable form of investing. These are a few great options for investors seeking discounted stocks.

Via InvestorPlace

The Cash Cow Cavalry: 3 Stocks Leading the Charge to Profitability ↗

March 21, 2024

Profitability drives a company's value in the market. These three stocks are headed toward stellar margins and profit growth!

Via InvestorPlace

The 3 Most Undervalued Stocks With Solid Fundamentals to Buy in March 2024 ↗

March 14, 2024

Undervalued companies with strong fundamental are always a great addition to an investment due to their inherent upside potential.

Via InvestorPlace

For those who appreciate value investing, NYSE:CAH is a compelling option with its solid fundamentals. ↗

March 13, 2024

CARDINAL HEALTH INC (NYSE:CAH), an undervalued stock with good fundamentals.

Via Chartmill

Cardinal Health Inc. (NYSE: CAH) Sets New 52-Week High in Tuesday Session

March 12, 2024

Via Investor Brand Network

For those who appreciate growth without the sticker shock, NYSE:CAH is worth considering. ↗

March 12, 2024

NYSE:CAH, a growth stock which is not overvalued.

Via Chartmill

If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today ↗

February 28, 2024

Via Benzinga

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today ↗

February 02, 2024

Via Benzinga

3 Top-Ranked Stocks To Buy For Stability ↗

March 06, 2024

Low-beta stocks can provide several beneficial advantages for portfolios, including defensive qualities and stabilization when combined with high-beta stocks, helping to provide a more balanced risk...

Via Talk Markets

3 Stocks to Buy at 52-Week Lows: March 4 Edition ↗

March 04, 2024

Sometimes a gem can get tossed in the trash, which is what you will find with these three stocks to buy at 52-week lows.

Via InvestorPlace

Shake Shack, Cardinal Health And More: CNBC's 'Final Trades' ↗

February 16, 2024

On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management said she likes Invesco S&P 500 Equal Weight Energy ETF (NYSE:

Via Benzinga

Topics ETFs

Dividend Income Update January 2024 ↗

February 15, 2024

It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio

Via Talk Markets

Cardinal Health Stock Shows Healthy Improvement To Its Technical Strength ↗

February 14, 2024

On Wednesday, Cardinal Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 69 to 78.

Via Investor's Business Daily

US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation ↗

February 14, 2024

FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scrutiny. Industry defends practices.

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.